期刊文献+

白念珠菌磷脂酶表达水平与氟康唑耐药关系的实验研究 被引量:1

Relationship between phospholipase expression and fluconazole resistance in Candida albicans
原文传递
导出
摘要 目的 探讨白念珠菌毒力因子磷脂酶B1与耐药间的关系.方法 实验用白念珠菌氟康唑耐药株和敏感株各15株,提取白念珠菌总RNA,应用RT-PCR检测比较其耐药株与敏感株磷脂酶B1mRNA的表达.盐析法提取白念珠菌耐药株与敏感株胞外蛋白,P0013B放射免疫沉淀分析(RIPA)裂解液(强)裂解提取细胞内蛋白质,以β-肌动蛋白为内参照,用Western印迹法分别比较胞内和胞外耐药株和敏感株磷脂酶B1蛋白的表达水平.结果 耐药株和敏感株磷脂酶B1mRNA的相对表达量分别为0.6173±0.1090和0.2653±0.0935,耐药株磷脂酶B1mRNA的表达强于敏感株(t=2.452,P<0.05).耐药株和敏感株胞内磷脂酶B1蛋白相对表达量为0.4145±0.2773和0.1825±0.1831,胞外磷脂酶B1蛋白相对表达量为0.2720±0.2194和0.0688±0.0631,耐药株胞内磷脂酶B1和细胞外分泌的磷脂酶B1蛋白表达水平均高于敏感株(t=2.703、3.443,P值均<0.05).结论 白念珠菌耐药株毒力因子磷脂酶B1mRNA及蛋白表达水平均高于敏感株.白念珠菌磷脂酶表达水平与耐药的发生可能存在一定关系. Objective To explore the relationship between antifungal resistance and expression of a virulence factor phospholipase B1 in Candida albicans. Methods Total RNA was extracted from 15 fluconazole-resistant and 15 fluconazole-sensitive Candida albicans isolates. RT-PCR was performed to detect the expression of phospholipase B1 mRNA. Extracellular and intracellular proteins secreted by Candida albicans cells were concentrated using salting-out method and extracted by P0013B RIPA lysis buffer, respectively followed by Western-blotting analysis to detect the expression of extracellular and intracellular phospholipase B1 protein. Results The relative expression of phospholipase B1 mRNA was 0.6173 ± 0.1090 in fluconazoleresistant Candida albicans isolates, significantly higher than in fluconazole-sensitive isolates (0.2653 ± 0.0935,P < 0.05). Increased expressions of extracellular and intracellular phospholipase B1 protein were noted in fluconazole-resistant Candida albicans isolates compared with fluconazole-sensitive isolates (0.4145 ± 0.2773 vs 0.2720 ± 0.2194, 0.1825 ± 0.1831 vs 0.2653 ± 0.0935, t = 2.703, 3.443, both P < 0.05). Conclusions The expressions of phospholipase B1 mRNA and protein are elevated in fluconazole-resistant Candida albicans isolates, suggesting that the expression of phospholipase B1 may be associated with the occurrence of antifungal resistance in Candida albicans.
作者 苏英 李春阳
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2010年第9期641-644,共4页 Chinese Journal of Dermatology
基金 国家自然科学基金(30471563)
关键词 白念珠菌 磷脂酶 耐药 MRNA 蛋白 Candida albicans Phospholipase Resistance mRNA Protein
  • 相关文献

参考文献11

  • 1Skrodeniene E,Dambrauskiene A,Vitkauskiene A.Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital.Medicina (Kaunas),2006,42 (4):294-299.
  • 2Law D,Moore CB,Wardle HM,et al.High prevalence of antifungal resistance in Candida spp.from patients with AIDS.J Antimicrob Chemother,1994,34(5):659-668.
  • 3Becker JM,Henry LK,Jiang W,et al.Reduced virulence of Candida albicans mutants affected in multidrug resistance.Infect Immun,1995,63(11):4515-4518.
  • 4Wu T,Wright K,Hurst SF,et al.Enhanced extracellular production of aspartyl proteinase,a virulence factor,by Candida albicans isolates following growth in subinhibitory concentrations of fluconazole.Antimicrob Agents Chemother,2000,44 (5):1200-1208.
  • 5苏英,李春阳.敏感和耐药白念珠菌磷脂酶活力与其毒力关系的研究[J].山东大学学报(医学版),2007,45(5):535-537. 被引量:4
  • 6Mukherjee PK,Chandra J,Kuhn DM,et al.Differential expression of Candida albicans phospholipase B (PLB1) under various environmental and physiological conditions.Microbiology,2003,149(P11):261-267.
  • 7Graybill JR,Montalbo E,Kirkpatrick W,et al.Fluconazole versus Candida albicans:a complex relationship.Antimicrob Agents Chemother,1998,42(11):2938-2942.
  • 8Lyon JP,de Resende MA.Correlation between adhesion,enzyme production,and susceptibility to fluconazole in Candida albicans obtained from denture wearers.Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2006,102(5):632-638.
  • 9Fekete-forgacs K,Gyure L,Lenkey B.Changes of virulence factors accompanying the phenomenon of induced fluconazole resistance in Candida albicans.Mycoses,2000,43(7-8):273-279.
  • 10Gottfredsson M,Jessup CJ,Cox GM,et al.Fungal phospholipase activity and susceptibility to lipid preparations of amphotericin B.Antimicrob Agents Chemother,2001,45(11):3231-3233.

二级参考文献12

  • 1苑天红,王明永,吴升伟,王正蓉,吴承龙.白念珠菌二相性与毒力关系的实验研究[J].中国皮肤性病学杂志,2004,18(10):580-581. 被引量:12
  • 2章强强.白念珠菌的毒力研究——磷脂酶活力的测定[J].中华皮肤科杂志,1994,27(5):304-305. 被引量:14
  • 3Skrodeniene E,Dambrauskiene A,Vitkauskiene A.Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital[J].Medicina(Kaunas),2006,42(4):294-299.
  • 4Law D,Moore CB,Wardle HM,et al.High prevalence of antifungal resistance in Candida spp.from patients with AIDS[J].Antimicrob Chemother,1994,34(5):659-668.
  • 5Becker JM,Henry LK,Koltin Y,et al.Reduced Virulence of Candida albicans mutants affected in multidrug resistance[J].Infect Immun,1995,63(11):4 515-4 518.
  • 6Wu T,Katherine W,Steven F,et al.Enhanced extracellular production of aspartyl proteinase,a virulence factor,by Candida albicans isolates following growth in subinhibitory concentrations of fluconazole[J].Antimicrob Chemother,2000,44(5):1 200-1 208.
  • 7Ghannoum MA.Potential role of phospholipases in virulence and fungal pathogenesis[J].Clin Microbiol Rev,2000,13(1):122-143.
  • 8Barret-Bee K,Hayes Y,Wilson RG,et al.A comparison of phospholipase activity,cellular adherence and pathogenicity of yeasts[J].J Gen Microbiol,1985,131(5):1 217-1 221.
  • 9Kothavade RJ,Panthaki MH.Evaluation of phospholipase activity of Candida albicans and its correlation with pathogenicity in mice[J].J Med Microbiol,1998,47(2):99-102.
  • 10Bosco VL,Birman EG,Cury AE,et al.Yeasts from the oral cavity of children with AIDS:exoenzyme production and antifungal resistance[J].Pesqui Odotol Bras,2003,17(3):217-222.

共引文献3

同被引文献5

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部